Average buy price is hidden here: this position was already held before our 13F history begins, so the opening cost is unknown and any average would understate it.
| Quarter | Action | Shares change | Est. value change | Δ Own | Shares held | Filing date |
|---|---|---|---|---|---|---|
| Q1 2022 | Exited | −50K | – | −100.0% | 0 | May 16, 2022 |
No change · Q2–Q4 2021 (3 quarters)
|
No change | – | – | – | 50K | – |
| Q1 2021 | First covered | – | – | – | 50K | May 17, 2021 |
Not currently. Tiger Global Management fully exited HCAT in Q1 2022, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Tiger Global Management held HCAT since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Yes. Tiger Global Management reduced and then fully exited HCAT by Q1 2022; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
None as of the latest filing: Tiger Global Management has exited HCAT. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Tiger Global Management began building the HCAT position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
